Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ARDX
A plaintiff-side law firm issued a Business Wire solicitation advertising a securities class action against Ardelyx (NASDAQ: ARDX) for alleged violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5. The putative class period runs from January 13, 2025 to August 6, 2026, with a lead plaintiff deadline of November 16, 2026. The complaint alleges Ardelyx made false and misleading statements, citing delays in new patient starts and prescription fulfillment for XPHOZAH and IBSRELA. This is law-firm marketing, not a disclosure from Ardelyx — no certified class, settlement, or new company statement appears in the release.
Key figures
- Statutes cited
- ["Section 10(b)","Section 20(a)","Rule 10b-5"]
- Class period end
- August 6, 2026
- Class period start
- January 13, 2025
- Lead plaintiff deadline
- November 16, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.